Statements (52)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:disease
metabolic disorder |
| gptkbp:affects |
humans
|
| gptkbp:cause |
heart attack
stroke blindness amputation |
| gptkbp:causedBy |
insulin resistance
insulin deficiency |
| gptkbp:complication |
gptkb:cardiovascular_disease
kidney failure peripheral neuropathy diabetic foot retinopathy |
| gptkbp:diagnosedBy |
gptkb:oral_glucose_tolerance_test
HbA1c test fasting blood glucose test |
| gptkbp:firstDescribed |
gptkb:Aretaeus_of_Cappadocia
|
| gptkbp:hasEnvironmentalComponent |
yes
|
| gptkbp:hasEpidemiology |
higher prevalence in some ethnic groups
increasing in children more common in adults |
| gptkbp:hasGeneticComponent |
yes
|
| gptkbp:hasType |
gptkb:gestational_diabetes
gptkb:type_2_diabetes type 1 diabetes |
| https://www.w3.org/2000/01/rdf-schema#label |
diabetes mellitus
|
| gptkbp:ICD-10_code |
E10–E14
|
| gptkbp:prevalence |
increasing worldwide
|
| gptkbp:prevention |
not smoking
healthy diet regular exercise limiting alcohol consumption maintaining healthy weight |
| gptkbp:riskFactor |
age
family history obesity physical inactivity poor diet |
| gptkbp:symptom |
fatigue
blurred vision frequent urination increased thirst unexplained weight loss slow healing of wounds |
| gptkbp:treatment |
exercise
diet modification oral hypoglycemic agents insulin therapy |
| gptkbp:bfsParent |
gptkb:cancer
gptkb:cardiovascular_disease |
| gptkbp:bfsLayer |
4
|